According to a new report by Polaris Market Research, the global biosimulation market was valued at USD 2.48 billion in 2021 and is projected to reach USD 8.65 billion by 2030, expanding at a CAGR of 15.8% over the forecast period. Growth is underpinned by rising research and development spending across the pharmaceutical and biotechnology industries, expanding adoption of biologics...